Pro: “Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation”
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- 2009
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- Administration, Oral (MeSH)
- Aged (MeSH)
- Anticoagulants (MeSH)
- Aspirin (MeSH)
- Atrial Fibrillation (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Clinical Trials as Topic (MeSH)
- Clopidogrel (MeSH)
- Contraindications (MeSH)
- Drug Therapy, Combination (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- International Normalized Ratio (MeSH)
- Intracranial Embolism (MeSH)
- Middle Aged (MeSH)
- Multicenter Studies as Topic (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Risk Factors (MeSH)
- Severity of Illness Index (MeSH)
- Thrombophilia (MeSH)
- Ticlopidine (MeSH)
- Warfarin (MeSH)
published in
- Thrombosis and Haemostasis Journal